Author: Steven Knievel

How Much Is Enough for Gilead?

Posted by | Aug 5, 2015 |

[Cross posted from Public Citizen, Link] In December 2013, Gilead received FDA approval for the first in a new generation of hepatitis C treatments. By all accounts, these treatments represent a cure for patients living with...

Read More

Follow

Facebook     Twitter

PIJIP

infojustice.org is  hosted by the Program on Information Justice and Intellectual Property at American University Washington College of Law.

Infojustice Roundup

Archives | Subscribe

Free to Share

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Blog Categories

Coronavirus
Trade Agreements
NAFTA
TPP
ACTA
Domestic Legislation
Domestic Policy & Litigation
Limitations and Exceptions
Creative Commons
Multilateral (WIPO, WTO, UN)
Takedowns
Access to Medicines
Empirical Research

Ahmed Abdel Latif
Alek Tarkowski
Alexander Dent
Allan Rocha de Souza
Andres Guadamuz
Andres Izquierdo
Brandon Butler
Brook Baker
Burcu Kilic
Carolina Botero
Carolina Rossini
Caroline Ncube
Carrie Sager
Celeste Drake
Christophe Geiger
David Levine
Eve Gray
Hafiz Aziz ur Rehman
Heesob Nam
Hong Xue
Jonathan Band
Jorge Contreras
Jimmy Koo
Joana Varon
Joe Karaganis
Krista Maier
Lina Diaz
Leanne O’Donnell
Marcela Palacio Puerta
Matthew Rimmer
Matthew Webb
Michael Carroll
Michael Geist
Michael Palmedo
Michael Smith
Miguel Morachimo
Meredith Jacob
Margot Kaminski
Pedro Mizukami
Peter Maybarduk
Pranesh Prakash
Rashmi Rangnath
Sangeeta Shashikant
Sara Bannerman
Stela Bivol
Sean Flynn
Stephanie Rosenberg
Susan Chalmers
Thiru Balasubramaniam
William Xu
Peter Yu

RSS Comments on:

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Civil Society Documents

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Comments on:

  • An error has occurred, which probably means the feed is down. Try again later.